ATE236638T1 - Neue verwendung von prostaglandinen - Google Patents

Neue verwendung von prostaglandinen

Info

Publication number: ATE236638T1
Authority: AT; Austria
Prior art keywords: prostaglandins; new use; prostaglandin; psoriasis; treatment
Prior art date: 1994-09-21

Application number

AT95933000T

Other languages

English (en)

Inventor

Johan Stjernschantz

Bahram Resul

Original Assignee

Synphora Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-21

Filing date

1995-09-19

Publication date

2003-04-15

1995-09-19 Application filed by Synphora Ab filed Critical Synphora Ab

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE236638T1 publication Critical patent/ATE236638T1/de

Links

229940094443 oxytocics prostaglandins Drugs 0.000 title 1
150000003180 prostaglandins Chemical class 0.000 title 1
BGKHCLZFGPIKKU-UHFFFAOYSA-N (13E,15S)-15-hydroxy-9-oxo-prosta-10,13-dienoic acid Natural products CCCCCC(O)C=CC1C=CC(=O)C1CCCCCCC(O)=O BGKHCLZFGPIKKU-UHFFFAOYSA-N 0.000 abstract 2
201000004681 Psoriasis Diseases 0.000 abstract 2
230000010261 cell growth Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT95933000T 1994-09-21 1995-09-19 Neue verwendung von prostaglandinen ATE236638T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9403158A SE9403158D0 (sv)	1994-09-21	1994-09-21	New use of prostaglandins
PCT/SE1995/001059 WO1996009055A1 (en)	1994-09-21	1995-09-19	New use of prostaglandins

Publications (1)

Publication Number	Publication Date
ATE236638T1 true ATE236638T1 (de)	2003-04-15

Family

ID=20395309

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT03000905T ATE330613T1 (de)	1994-09-21	1995-09-19	Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
AT95933000T ATE236638T1 (de)	1994-09-21	1995-09-19	Neue verwendung von prostaglandinen

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT03000905T ATE330613T1 (de)	1994-09-21	1995-09-19	Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis

Country Status (10)

Country	Link
US (1)	US6031001A (de)
EP (2)	EP1310256B1 (de)
JP (1)	JP4044611B2 (de)
AT (2)	ATE330613T1 (de)
AU (1)	AU705901B2 (de)
CA (1)	CA2200480C (de)
DE (2)	DE69535081T2 (de)
ES (2)	ES2194055T3 (de)
SE (1)	SE9403158D0 (de)
WO (1)	WO1996009055A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5981586A (en) *	1997-05-23	1999-11-09	Pershadsingh; Harrihar A.	Methods for treating proliferative and inflammatory skin diseases
SE9702681D0 (sv) *	1997-07-10	1997-07-10	Pharmacia & Upjohn Ab	Method and composition for treatment of impotence
FR2773075B1 (fr)	1997-12-31	2000-05-05	Cird Galderma	Utilisation d'activateurs de ppar-gamma en dermatologie
SE9900672D0 (sv)	1999-02-25	1999-02-25	Synphora Ab	Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
ES2232434T3 (es)	1999-03-05	2005-06-01	Duke University	Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US6894175B1 (en)	1999-08-04	2005-05-17	The Procter & Gamble Company	2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) *	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) *	2000-03-31	2002-10-10	Delong Mitchell Anthony	Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) *	2000-03-31	2002-03-28	Delong Mitchell Anthony	Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) *	2000-03-31	2002-11-21	Delong Michell Anthony	Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
DE60236273D1 (de) *	2001-05-03	2010-06-17	Cornell Res Foundation Inc	Behandlung von krankheiten, die durch hpv verursacht werden
WO2003057162A2 (en) *	2002-01-04	2003-07-17	Combinatorx, Incorporated	Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
WO2003092617A2 (en) *	2002-05-03	2003-11-13	Combinatorx, Incorporated	Combinations for the treatment of inflammatory skin disorders
AU2003221707A1 (en) *	2002-06-14	2003-12-31	Alcon, Inc.	Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
SE0402029D0 (sv) *	2004-08-17	2004-08-17	Synphora Ab	Prostaglandin a derivatieves for the treatment of psoriasis
KR100760430B1 (ko) *	2004-12-31	2007-10-04	한미약품 주식회사	당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
US8722739B2 (en)	2008-10-29	2014-05-13	Novaer Holdings, Inc.	Amino acid salts of prostaglandins
US8623918B2 (en) *	2008-10-29	2014-01-07	Novaer Holdings, Inc.	Amino acid salts of prostaglandins
US9328060B2 (en)	2013-10-18	2016-05-03	East Carolina University	J-series prostaglandin-ethanolamides as novel therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4009282A (en) *	1973-12-17	1977-02-22	The Regents Of The University Of Michigan	Treatment of proliferating skin diseases with prostaglandins
DE2460285A1 (de) *	1973-12-25	1975-07-03	Ono Pharmaceutical Co	Trans-delta hoch 2-prostaglandinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4254145A (en) *	1978-08-16	1981-03-03	American Cyanamid Company	Topical application of prostaglandin hypotensive agents
JPS58216155A (ja) *	1982-06-10	1983-12-15	Ono Pharmaceut Co Ltd	新規なプロスタグランジンｄ類似化合物
EP0242580B1 (de) *	1986-03-13	1993-04-28	The Trustees Of Columbia University In The City Of New York	Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
ES2062102T5 (es) *	1988-09-06	2004-12-01	Pharmacia Ab	Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
CZ277720B6 (en) *	1990-12-29	1993-03-17	Vysoka Skola Chem Tech	Pharmaceutic gel containing natural prostaglandins for topic use

1994
- 1994-09-21 SE SE9403158A patent/SE9403158D0/xx unknown
1995
- 1995-09-19 EP EP03000905A patent/EP1310256B1/de not_active Expired - Lifetime
- 1995-09-19 AU AU35817/95A patent/AU705901B2/en not_active Ceased
- 1995-09-19 EP EP95933000A patent/EP0778774B1/de not_active Expired - Lifetime
- 1995-09-19 DE DE69535081T patent/DE69535081T2/de not_active Expired - Fee Related
- 1995-09-19 CA CA002200480A patent/CA2200480C/en not_active Expired - Fee Related
- 1995-09-19 US US08/809,017 patent/US6031001A/en not_active Expired - Fee Related
- 1995-09-19 ES ES95933000T patent/ES2194055T3/es not_active Expired - Lifetime
- 1995-09-19 AT AT03000905T patent/ATE330613T1/de not_active IP Right Cessation
- 1995-09-19 AT AT95933000T patent/ATE236638T1/de not_active IP Right Cessation
- 1995-09-19 JP JP51080696A patent/JP4044611B2/ja not_active Expired - Fee Related
- 1995-09-19 DE DE69530303T patent/DE69530303T2/de not_active Expired - Fee Related
- 1995-09-19 WO PCT/SE1995/001059 patent/WO1996009055A1/en not_active Ceased
- 1995-09-19 ES ES03000905T patent/ES2263853T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU3581795A (en)	1996-04-09
DE69530303D1 (de)	2003-05-15
JPH10505861A (ja)	1998-06-09
DE69530303T2 (de)	2004-02-12
ES2263853T3 (es)	2006-12-16
JP4044611B2 (ja)	2008-02-06
CA2200480A1 (en)	1996-03-28
ATE330613T1 (de)	2006-07-15
SE9403158D0 (sv)	1994-09-21
EP1310256A2 (de)	2003-05-14
ES2194055T3 (es)	2003-11-16
WO1996009055A1 (en)	1996-03-28
US6031001A (en)	2000-02-29
DE69535081T2 (de)	2007-06-28
CA2200480C (en)	2003-03-25
EP0778774B1 (de)	2003-04-09
AU705901B2 (en)	1999-06-03
EP1310256A3 (de)	2003-06-25
EP1310256B1 (de)	2006-06-21
EP0778774A2 (de)	1997-06-18
DE69535081D1 (de)	2006-08-03

Legal Events

Date	Code	Title	Description
2003-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE236638T1 (de)	2003-04-15	Neue verwendung von prostaglandinen
UA19303A (uk)	1997-12-25	Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
DE3770657D1 (de)	1991-07-18	Fungizide verwendung eines cyanopyrrol-derivates.
DK357386D0 (da)	1986-07-28	Saarhelende midler
ATE225168T1 (de)	2002-10-15	Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen
ATE72238T1 (de)	1992-02-15	Imidazoliumsalze, zwischenprodukte fuer ihre herstellung sowie ihre verwendung.
DE69719931D1 (de)	2003-04-24	Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
IT1170214B (it)	1987-06-03	Composizione farmaceutica per la cura delle arteriopatie periferiche
DE69130497D1 (de)	1998-12-24	Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE43244T1 (de)	1989-06-15	Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
ATE80616T1 (de)	1992-10-15	Prostaglandin e1-derivate und ihre therapeutische anwendung.
ATE161725T1 (de)	1998-01-15	Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE69227583D1 (de)	1998-12-17	Arylmorpholine, herstellung und verwendung
AU570552B2 (en)	1988-03-17	1,4-dihydropyridine-3-carboxylates and salts thereof
FR2434804A1 (fr)	1980-03-28	Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
DE69132050D1 (de)	2000-04-20	Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
NZ335057A (en)	2000-09-29	Pentaerythritol derivatives, their production and use and intermediates for their synthesis
ATE135364T1 (de)	1996-03-15	Wasserfreie kristalle von 4-carbamoyl-1-beta-d- ribofuranosyl-imidazolium-5-olat
IT1199960B (it)	1989-01-05	Agenti stimolanti la crescita dei capelli e loro impiego
MD996G2 (ro)	1999-05-31	Metodă de tratament a cistitei
ATE155479T1 (de)	1997-08-15	Neue cytarabin-derivate, ihre herstellung und verwendung